Related Experiment Video
Updated: Jul 1, 2026

05:17
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
1.7K
Solvent-Free Synthesis, In Vitro and In Silico Studies of Novel Potential 1,3,4-Thiadiazole-Based Molecules against
Ihsan A Shehadi1, Mohamad T Abdelrahman2, Mohamed Abdelraof3
1Pure and Applied Chemistry Research Group, Department of Chemistry, College of Sciences, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates.
Molecules (Basel, Switzerland)
|January 21, 2022
Summary
New 1,3,4-thiadiazole derivatives were synthesized and screened for antimicrobial activity. Compound 3 demonstrated significant broad-spectrum antimicrobial and antifungal effects, showing promise for drug development.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Microbiology
Background:
- 1,3,4-thiadiazoles are a class of heterocyclic compounds with diverse biological activities.
- Developing novel antimicrobial agents is crucial due to rising drug resistance.
Purpose of the Study:
- To synthesize novel 1,3,4-thiadiazole derivatives.
- To evaluate their in vitro antimicrobial and antifungal activities.
- To investigate their binding interactions with microbial enzymes using molecular docking.
Main Methods:
- Synthesis of 1,3,4-thiadiazoles via grinding method at room temperature.
- Structural elucidation using spectral and microanalytical data.
- Antimicrobial screening against Gram-positive and Gram-negative bacteria and fungi.
- Molecular docking against tyrosyl-tRNA synthetase (TyrRS) and N-myristoyl transferase (Nmt).
Main Results:
- Several novel 1,3,4-thiadiazole derivatives were successfully synthesized.
- Compounds 3 and 5 exhibited significant antimicrobial activity against all tested microorganisms.
- Compound 3 showed potent antifungal activity and favorable binding interactions with microbial enzymes.
- Compound 3 displayed the best binding affinity (-9.1 kcal/mol) and hydrogen bonding interactions.
Conclusions:
- Compound 3 is a promising candidate for further development as an antimicrobial agent.
- The synthesized 1,3,4-thiadiazoles show potential for combating microbial infections.
- In silico and in vitro studies support the therapeutic potential of compound 3.

